Surgery and antibiotics for the treatment of lupus nephritis with cerebral abscesses: A case report

Table 2 History of treatment in the past year

Date	Treatment		Drug-specific
Treatment (April-December 2017)	Phase 1	Primary treatment	Methylprednisolone shock therapy (500 mg/d/3D)/hemodialysis 5 times, once every other day (due to progressive increase in serum creatinine to 455 μmol/L)/intravenous immunoglobulin
		Adjuvant treatment	Symptomatic treatments to control infection/supplement albumin and supplement thyroxine
	Phase 2	Primary treatment	Prednisone 60 mg/d QD maintenance/cyclophosphamide shock therapy (European protocol)
		Adjuvant treatment	Infection control/platelet infusion
After discharge (December 2017 – April 2018)	Primary treatment		Oral prednisone 40 mg/d, outpatient follow-up, monthly gradually reduced to 20 mg/d/oral MMF 1.5 g bid
Return for treatment due to lung infection (April 2018)	Primary treatment		The prednisone and MMF schemes remained unchanged /Immunomodulatory and anti-infective therapy for lung infection
After discharge(April-May 2018)	Primary treatment		Oral prednisone 20 mg/d/ oral MMF 1.0 g bid
June 2018	Admitted to hospital due to multiple brain abscesses

MMF: Mycophenolate mofetil.